Nervous System Neoplasms  >>  Torisel (temsirolimus)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Torisel (temsirolimus) / Pfizer
NCT01019434 / 2008-003003-31: Radiation Therapy and Temsirolimus or Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Checkmark ASCO 2014
May 2014 - May 2014: ASCO 2014
Completed
2
111
Europe
temozolomide, temsirolimus
European Organisation for Research and Treatment of Cancer - EORTC, Pfizer
Brain and Central Nervous System Tumors
12/13
03/14
NCT01614795: Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma

Checkmark ASCO 2014
May 2014 - May 2014: ASCO 2014
Completed
2
46
Canada, US
Cixutumumab, Anti-IGF-1R Recombinant Monoclonal Antibody IMC-A12, IMC-A12, Laboratory Biomarker Analysis, Temsirolimus, CCI-779, CCI-779 Rapamycin Analog, Cell Cycle Inhibitor 779, Rapamycin Analog, Rapamycin Analog CCI-779, Torisel
National Cancer Institute (NCI)
Childhood Alveolar Soft Part Sarcoma, Childhood Angiosarcoma, Childhood Epithelioid Sarcoma, Childhood Fibrosarcoma, Childhood Gliosarcoma, Childhood Leiomyosarcoma, Childhood Liposarcoma, Childhood Malignant Peripheral Nerve Sheath Tumor, Childhood Synovial Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Osteosarcoma, Rhabdomyosarcoma
04/14
04/14
NCT00022724: CCI-779 in Treating Patients With Malignant Glioma

Completed
1/2
49
US
temsirolimus
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, National Cancer Institute (NCI)
Brain and Central Nervous System Tumors
05/06
12/07
NCT00112736: Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma

Checkmark Erlotinib & temsirolimus for pts with recurrent malignant gliomas
Jan 2014 - Jan 2014: Erlotinib & temsirolimus for pts with recurrent malignant gliomas
Completed
1/2
69
US
erlotinib, CP-358,774, erlotinib hydrochloride, OSI-774, temsirolimus, CCI-779, cell cycle inhibitor 779, Torisel, therapeutic conventional surgery, laboratory biomarker analysis, pharmacological study, pharmacological studies
National Cancer Institute (NCI)
Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Diffuse Astrocytoma, Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Adult Mixed Glioma, Adult Pilocytic Astrocytoma, Adult Pineal Gland Astrocytoma, Adult Subependymal Giant Cell Astrocytoma, Recurrent Adult Brain Tumor
04/10
04/14

Download Options